Most of these Tc17 cells in the tumor margin are able to produce IFN-γ in addition to IL-17A, as opposed to the dominant subset of circulating Tc17 cells in HCC patients, which do not coproduce IFN-γ [194]. The gene discussed is IL17A; the disease is hepatocellular carcinoma.